Mohri Y, Tonouchi H, Kobayashi M, Nakai K, Kusunoki M
Department of Gastrointestinal Surgery and Paediatric Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Br J Surg. 2007 Jun;94(6):683-8. doi: 10.1002/bjs.5837.
The optimum duration of antimicrobial prophylaxis in elective gastric cancer surgery is still open to question. This multicentre randomized clinical trial compared a single-dose with a multiple-dose regimen of antimicrobial prophylaxis for prevention of surgical-site infection.
Between May 2001 and December 2004, 501 patients undergoing elective surgery for gastric cancer in ten centres were allocated randomly to single- or multiple-dose antimicrobial prophylaxis. The primary outcome measure was the incidence of surgical-site infection, analysed by intention to treat.
Some 243 patients who received a single dose and 243 who received multiple doses of antibiotics were included in the final analysis. The surgical-site infection rate was 9.5 per cent (23 of 243) and 8.6 per cent (21 of 243) respectively (difference 0.9 (95 per cent confidence interval - 4.3 to 5.9) per cent). Antimicrobial prophylaxis had no major adverse effects.
The incidence of surgical-site infection in elective gastric cancer surgery was similar with both antibiotic prophylaxis regimens.
择期胃癌手术中抗菌药物预防性应用的最佳持续时间仍存在疑问。这项多中心随机临床试验比较了单剂量与多剂量抗菌药物预防性应用方案预防手术部位感染的效果。
2001年5月至2004年12月期间,10个中心的501例接受择期胃癌手术的患者被随机分配接受单剂量或多剂量抗菌药物预防性应用。主要结局指标是手术部位感染的发生率,采用意向性分析。
最终分析纳入了约243例接受单剂量抗生素治疗的患者和243例接受多剂量抗生素治疗的患者。手术部位感染率分别为9.5%(243例中的23例)和8.6%(243例中的21例)(差异为0.9(95%置信区间为-4.3至5.9)%)。抗菌药物预防性应用没有重大不良反应。
两种抗生素预防性应用方案在择期胃癌手术中手术部位感染的发生率相似。